Robert S Seitz

Dual Prognostic Classification of Triple-Negative Breast Cancer by DNA Damage Immune Response and Homologous Recombination Deficiency.

G. Hortobagyi, P. Sharma, S. Stecklein, 2023, JCO precision oncology.

Spatial predictors of immunotherapy response in triple-negative breast cancer

P. Valagussa, H. R. Ali, M. Colleoni, 2023, Nature.